Robinhood RVII: What Every Investor Needs to Know About the $25 Y Combinator Fund

Robinhood Ventures Fund II (RVII) began trading on the NYSE on August 13, 2026 at an IPO price of $25 per share, targeting up to $200 million to invest in roughly 80 Y Combinator-linked seed-stage startups . It requires no accreditation and has no investment minimum, making early-stage venture exposure available to any retail investor . But beneath the accessible entry price sits a complex and costly structure that its predecessor RVI has already demonstrated can lead to significant losses.

How RVII Works: Closed-End Fund Structure

RVII is structured as a business development company (BDC), a type of closed-end fund created by Congress in 1980 to channel retail capital into private companies . Unlike an open-end mutual fund or ETF, the number of shares is fixed at the IPO; shares then trade on the open market like a stock, and the market price can deviate — often dramatically — from the fund's net asset value (NAV) .

The fund provides daily liquidity on the NYSE under ticker RVII , but it has no fixed fund life and no mandated distributions. Returns depend almost entirely on share price appreciation rather than dividends or payouts .

Importantly, holders own shares of the fund, not direct stakes in the startups themselves — you own a piece of the fund that owns the equity in Y Combinator companies .

The Cost: 4.18% Annual Expenses Plus 20% Carry

RVII uses what the venture capital industry calls a "2-and-20" fee model, which is significantly more expensive than typical retail funds :

• Base management fee: 2% of net assets annually .
• Performance fee (carried interest): 20% of realized capital gains above certain hurdles .
• Total annual expense ratio: Estimated at roughly 4.18% when combining management fees, administration fees, and organizational expenses .

To put that in perspective: a typical S&P 500 index fund charges roughly 0.03% annually. RVII's expenses mean the underlying portfolio must grow by at least 4.18% every year just to break even, before the manager takes an additional 20% of any profits.

The predecessor fund RVI charged only a 2% management fee with no carried interest . RVII's addition of performance fees makes it notably pricier.

The Precedent: RVI's Track Record Is a Warning

RVI, the direct predecessor, launched in September 2025 and listed on the NYSE on March 6, 2026 at $25/share . Its track record provides the closest available precedent for what RVII investors might expect.

Key RVI Performance Data (as of mid-August 2026)

Metric	RVI Value	Source
NAV return (inception to March 31, 2026)	+0.85%
Post-IPO NAV return (Mar 6 – Mar 31, 2026)	-3.80%
Post-IPO share-price total return (same period)	+6.16%
Share price (Aug 14, 2026)	$28.56
52-week range	$21.00 – $77.39
Premium to NAV	Routinely 10–30%; recently ~90%

Four Takeaways From RVI That Apply Directly to RVII

1. Massive market-price volatility. RVI fell 11% on its first trading day , then later surged to a 52-week high of $77.39 before settling back to roughly $28.56 . The market price has repeatedly traded at enormous premiums — sometimes near 90% — far above the underlying NAV of about $24.70 . Investors who bought at the peak likely incurred severe losses.

2. Underlying portfolio returns are essentially flat. NAV growth from inception through March 31, 2026 was only 0.85% — barely positive — and actually declined by -3.80% after the IPO date . The private portfolio has not yet produced meaningful appreciation.

3. Closed-end structure creates "premium risk." RVI's market price has detached dramatically from its NAV. Investors buying at the highs paid roughly 3x the actual value of the underlying startups — a risk analysts have warned could lead to downside exceeding 50% .

4. No carried interest in RVI meant lower fee drag, yet performance was still muted . RVII's added 20% performance fee could further erode net returns.

Core Risks Every RVII Investor Should Understand

RVII carries risks beyond those of a typical stock or ETF:

• Illiquid private assets. The underlying startups are not publicly traded, so NAV is based on subjective quarterly valuations, not continuous market prices .
• Concentration risk. The fund is non-diversified and focused only on Y Combinator seed-stage companies .
• High fee drag. Roughly 4.18% annual expenses plus 20% of profits significantly eat into net returns compared with a low-cost index fund .
• No guarantee of exits. Most startups fail, and even Y Combinator's overall portfolio includes many that return zero .
• First-day pop reversed. RVI opened at a premium and promptly dropped 11% ; RVII could follow a similar pattern.

Bottom Line

RVII democratizes access to Y Combinator seed investing for $25/share with no accreditation required, but it does so through a high-fee (4.18% + 20% carry), closed-end structure where the traded share price may decouple wildly from the underlying startup portfolio's actual value. The RVI precedent shows that early investors who bought at premium prices suffered steep losses, while the underlying startup investments produced near-zero NAV growth so far. RVII is a speculative, long-duration bet on YC's startup pipeline, not a conventional investment — and the fee structure means the fund manager gets paid meaningfully even if returns are modest or negative.